CytoDyn to Present at Wall Street Reporter’s “
Post# of 148185
(Total Views: 523)
Posted On: 04/16/2020 6:01:17 AM
CytoDyn to Present at Wall Street Reporter’s “NEXT SUPER STOCK” Livestream Event on April 17, 2020 at 12:30 pm ET / 9:30 am PT
CytoDyn to Present at Wall Street Reporter’s “NEXT SUPER STOCK” Livestream Event on April 17, 2020 at 12:30 pm ET / 9:30 am PT
Download as PDFApril 16, 2020 6:00am EDT
VANCOUVER, Washington, April 16, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"
, a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader Pourhassan, Ph.D., President and Chief Executive Officer, will appear as a panelist at Wall Street Reporter’s “NEXT SUPER STOCK” Livestream event on Friday, April 17, 2020 at 12:30 pm ET / 9:30 am PT.
Date: Friday, April 17, 2020
Time: 12:30 pm ET / 9:30 am PT
Access: https://attendee.gotowebinar.com/register/607...9315473677
Dr. Pourhassan will be joined by Jacob Lalezari, M.D., Chief Executive Officer of Quest Clinical Research and Bruce Patterson, M.D., Chief Executive Officer and founder of IncellDx, a diagnostic partner and an advisor to CytoDyn, to discuss CytoDyn’s two clinical trials with leronlimab as a treatment for COVID-19.
The livestream presentation will be archived for 30 days and participants are encouraged to go to the above-referenced website 10 minutes prior to the start of the presentation. For anyone unable to attend, a video will be posted on CytoDyn’s website approximately 24 hours after the presentation. The conference sponsor provides corporate visibility services to CytoDyn for a fee.
CytoDyn to Present at Wall Street Reporter’s “NEXT SUPER STOCK” Livestream Event on April 17, 2020 at 12:30 pm ET / 9:30 am PT
Download as PDFApril 16, 2020 6:00am EDT
VANCOUVER, Washington, April 16, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"
, a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader Pourhassan, Ph.D., President and Chief Executive Officer, will appear as a panelist at Wall Street Reporter’s “NEXT SUPER STOCK” Livestream event on Friday, April 17, 2020 at 12:30 pm ET / 9:30 am PT. Date: Friday, April 17, 2020
Time: 12:30 pm ET / 9:30 am PT
Access: https://attendee.gotowebinar.com/register/607...9315473677
Dr. Pourhassan will be joined by Jacob Lalezari, M.D., Chief Executive Officer of Quest Clinical Research and Bruce Patterson, M.D., Chief Executive Officer and founder of IncellDx, a diagnostic partner and an advisor to CytoDyn, to discuss CytoDyn’s two clinical trials with leronlimab as a treatment for COVID-19.
The livestream presentation will be archived for 30 days and participants are encouraged to go to the above-referenced website 10 minutes prior to the start of the presentation. For anyone unable to attend, a video will be posted on CytoDyn’s website approximately 24 hours after the presentation. The conference sponsor provides corporate visibility services to CytoDyn for a fee.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼